KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cdw (CDW) Cash & Equivalents (2016 - 2025)

Cdw's Cash & Equivalents history spans 16 years, with the latest figure at $618.7 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 22.88% year-over-year to $618.7 million; the TTM value through Dec 2025 reached $618.7 million, up 22.88%, while the annual FY2025 figure was $618.7 million, 22.88% up from the prior year.
  • Cash & Equivalents reached $618.7 million in Q4 2025 per CDW's latest filing, up from $452.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $946.7 million in Q3 2024 to a low of $203.9 million in Q2 2023.
  • Average Cash & Equivalents over 5 years is $498.4 million, with a median of $476.2 million recorded in 2025.
  • The largest YoY upside for Cash & Equivalents was 309.79% in 2021 against a maximum downside of 81.7% in 2021.
  • A 5-year view of Cash & Equivalents shows it stood at $258.1 million in 2021, then grew by 22.12% to $315.2 million in 2022, then soared by 86.77% to $588.7 million in 2023, then decreased by 14.47% to $503.5 million in 2024, then grew by 22.88% to $618.7 million in 2025.
  • Per Business Quant, the three most recent readings for CDW's Cash & Equivalents are $618.7 million (Q4 2025), $452.9 million (Q3 2025), and $481.0 million (Q2 2025).